Apimeds Share Price

Apimeds Share Price

AMEX: APUS | Healthcare
$1.86
+$1.86 (--%) Last updated on 19 Nov, 2026 | 02:23 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

Apimeds Stock Performance

Open
$1.94
Prev. Close
N/A
Circuit Range
N/A
Day Range
$1.86 - $2.07
Year Range
$0.62 - $9.71
Volume
1,670
Average Traded
$1.99

Apimeds Share Price Chart

Line chart of the Apimeds price trend over the selected period. The price rose overall, ranging from 1.86 to 2.16, ending at 1.86.
$1.86$2.07
L
Show Current Price
H

Apimeds Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-38.55
Revenue (TTM)
$0.00
Return On Equity (TTM)
-54.65%
Profit Margin
N/A
Debt to Equity
0.08
Quarterly Earnings Growth YoY
-1033.15%

Apimeds Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$1.78-$1.16-$35.06-$20.17
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A34.83%-2922.41%42.47%

Apimeds Annual Profit & Loss

All figures in USD

Particulars2025
Revenue$0.00
Net Profit-$6.00
Net Profit MarginN/A
Income ChangeN/A

Apimeds Balance Sheet

All figures in USD Million

Particulars2025
Non Current Assets150.2
Current Assets13.98
Total Assets164.18
Non Current Liabilities0.13
Current Liabilities10.71
Total Liabilities10.84
Shareholders' Equity153.35

Apimeds Cash Flow

Annually

All figures in USD Million

Particulars2025
Operating-8.93
Investing-10.06
Financing20.62

Corporate Actions

Split
Ex-date: 24 Jul 2026

About Apimeds

Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being evaluated for the treatment of pain and inflammation associated with knee osteoarthritis. The Company operates in two segments: the biopharmaceutical segment, which is focused on the clinical development of Apitox through Lokahi, and the digital asset operations segment, which encompasses the holding, sale, and advancement of the MindWaveDAO blockchain and related digital assets through MindWave.

Apimeds Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$2.91
$1.86
-36.95%
Oct 2026
$4.96
$2.95
-40.76%
Sep 2026
$2.57
$4.98
+1.22%
Aug 2026
$4.94
$4.92
-15.32%
Jul 2026
$0.89
$5.81
+583.53%
Jun 2026
$1.26
$0.85
-40.97%
May 2026
$5.77
$1.44
-15.79%
Apr 2026
$1.71
$1.71
-1.16%
Mar 2026
$1.43
$1.73
+37.85%
Feb 2026
$1.94
$1.25
-33.60%
Jan 2026
$1.73
$1.89
+2.72%
Dec 2025
$3.20
$1.84
-35.44%

Apimeds Share Price FAQs